Purdue Pharma, the maker of Oxycontin who some have blamed for the epidemic of opioid painkiller addictions, has patented a medicine aimed at curbing those disorders.
Latest Chronic Pain News
The new anti-addiction drug is a fast-acting form of buprenorphine, which helps control drug cravings, CBS News reported. Previously prescribed in either tablet or fast-dissolving strips, the Purdue version comes in a “wafer” that dissolves in only a few seconds.
Richard Sackler, a member of Purdue’s board, is listed as one of the inventors on the patent, CBS said. The Sackler family controls Purdue.
The announcement comes as Purdue finds itself in the middle of numerous lawsuits from states accusing the company of helping to create the opioid addiction crisis.
In one lawsuit, the Massachusetts attorney general accused Purdue of a “deadly, deceptive scheme to sell opioids.” Purdue and the Sackler family deny the allegations.
Last week, Purdue donated $3.4 million to the developer of an over-the-counter version of naloxone, a drug often used to prevent a fatal opioid overdose. Purdue said it will not receive royalties from the new form of naloxone, which is being developed by Harm Reduction Therapeutics, CBS said.
Copyright © 2018 HealthDay. All rights reserved.
CONTINUE SCROLLING FOR NEXT NEWS ARTICLE
This information is designed for educational purposes only and should not be used in any other manner. This information is not intended to substitute for informed medical advice. You should not use this information to diagnose or treat a health problem or disease without consulting with a qualified health care provider. A consultation with your health care professional is the proper method to address your health concerns. You are encouraged to consult your health care provider with any questions or concerns you may have regarding your condition. Rapid advances in medicine may cause information contained here to become outdated, invalid or subject to debate. Accuracy cannot be guaranteed.